Skip to main content
Log in

Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

One hundred and four pathogenic yeast isolates (32Candida albicans, 20 Candida tropicalis, 20Candida parapsilosis and 32Cryptococcus neoformans) and 21 mould isolates (13Aspergillus spp. and eightFusarium spp.), most of which were isolated from patients with cancer, were tested for susceptibility to free amphotericin B and a small unilamellar liposomal formulation of amphotericin B using a microbroth dilution method. Minimal fungicidal concentrations were also determined forCandida spp. andCryptococcus neoformans. The minimal inhibitory concentrations of liposomal amphotericin B were comparable with those of the free drug; furthermore, the fungicidal activity of these two drugs did not differ significantly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Drouhet E, Dupont B Evolution of antifungal agents: past, present, and future. Reviews of Infectious Diseases 1987, 9, Supplement 1: 4–14.

    Google Scholar 

  2. Bodey GP Topical and systemic antifungal agents. Medical Clinics of North America 1988, 72: 637–659.

    PubMed  Google Scholar 

  3. Lopez-Berestein G, Mehta R, Hopfer RL, Mills K, Kasi L, Mehta K, Fainstein V, Luna M, Hersh EM, Juliano R Treatment and prophylaxis of disseminatedCandida albicans infection in mice with liposome encapsulated amphotericin B. Journal of Infectious Diseases 1983, 147: 939–945.

    PubMed  Google Scholar 

  4. Hopfer RL, Mills K, Mehta R, Lopez-Berestein G, Fainstein V, Juliano RL In vitro antifungal activities of amphotericin B and liposome encapsulated amphotericin B. Antimicrobial Agents and Chemotherapy 1984, 25: 387–389.

    PubMed  Google Scholar 

  5. Gondal JA, Swartz RP, Rahman A Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrobial Agents and Chemotherapy 1989, 33: 1544–1548.

    PubMed  Google Scholar 

  6. Katz NM, Pierce PF, Anzeck RA, Visner MS, Canter HG, Foegh ML, Pearle DL, Tracy C, Rahman A Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient. Journal of Heart Transplantation 1990, 9: 14–17.

    PubMed  Google Scholar 

  7. Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG Multicenter evaluation of four methods of yeast inoculum preparation. Journal of Clinical Microbiology 1988, 26: 1437–1441.

    PubMed  Google Scholar 

  8. Ericsson HM, Sherris J Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica (B) 1971, 217, Supplement: 1–90.

    Google Scholar 

  9. Chowdhury MKR, Goswami R, Chakrabarti P Liposome-trapped penicillins in growth inhibition of some penicillin-resistant bacteria. Journal of Applied Bacteriology 1981, 51: 223–227.

    PubMed  Google Scholar 

  10. Szoka FC, Milholland D, Barza M Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrobial Agents and Chemotherapy 1987, 31: 421–429.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anaissie, E., Paetznick, V., Proffitt, R. et al. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis. 10, 665–668 (1991). https://doi.org/10.1007/BF01975823

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01975823

Keywords

Navigation